Cambridge Investment Research Advisors’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
+10,132
| New | +$19K | ﹤0.01% | 3581 |
|
|
2023
Q2 | – | Sell |
-158
| Closed | -$12K | – | 3226 |
|
|
2023
Q1 | $12K | Hold |
158
| – | – | ﹤0.01% | 3128 |
|
|
2022
Q4 | $14K | Sell |
158
-37
| -19% | -$3.28K | ﹤0.01% | 3069 |
|
|
2022
Q3 | $11K | Buy |
195
+44
| +29% | +$2.48K | ﹤0.01% | 3021 |
|
|
2022
Q2 | $18K | Buy |
151
+6
| +4% | +$715 | ﹤0.01% | 3005 |
|
|
2022
Q1 | $42K | Buy |
+145
| New | +$42K | ﹤0.01% | 3088 |
|